Catalyst Wire Dossier Catalyst Wire Dossier

Laquinimod

laquinimod · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Laquinimod, covering 2011-04-08 to 2022-07-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis [Phase 2]

See pricing